Slow IOL insertion affects wound structure

Article

Slow IOL injection affects corneal wound structure, compared to fast IOL insertion.

Slow IOL injection affects corneal wound structure, compared to fast IOL insertion.

The prospective randomized clinical trial. Headed by Dr Masayuki Ouchi, Ouchi Eye Clinic and the Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan, enrolled 80 eyes that underwent phacoemulsification and IOL implantation using a screw-plunger injector.

All patients were randomized into two equal groups. Group F underwent fast IOL insertion and Group S experienced slow IOL insertion. The team compared change in wound-size preoperatively/postoperatively, need for corneal hydration, surgically induced astigmatism (SIA) and optical coherence tomography (OCT) results of the corneal wound structure.

It was discovered that wound size changes were significantly larger in Group S and the OCT results were more prominent. Corneal hydration was needed in 11 eyes in Group F and 40 in Group S.

The study can be found in the Journal of Cataract and Refractive Surgery.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.